Germline EGFR T790M mutation found in multiple members of a familial cohort

Journal of Thoracic Oncology

Volumn 9, Issue 4, 2014, Pages 554-558

  Yu, Helena A ^a,d   Arcila, Maria E ^b   Fleischut, Megan Harlan ^c   Stadler, Zsofia ^c   Ladanyi, Marc ^b   Berger, Michael F ^b   Robson, Mark ^c   Riely, Gregory J ^a,d  

^a Division of Solid Tumor Oncology   (United States)

^b Department of Pathology ^*  (United States)

^c Clinical Genetics Service   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EGFR PROTEIN, HUMAN; PROTEIN KINASE INHIBITOR;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BRCA2 GENE; BREAST CANCER; CANCER GROWTH; CASE REPORT; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; EGFR GENE; EXON; FAMILY; FAMILY HISTORY; FEMALE; GENE DELETION; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENOMIC FRAGMENT; GERMLINE MUTATION; GROUND GLASS OPACITY; HUMAN; HUMAN TISSUE; LEFT LOWER LOBE NODULE; LEFT UPPER LOBE NODULE; LUNG ADENOCARCINOMA; LUNG BIOPSY; LUNG CARCINOGENESIS; LUNG NODULE; METASTASIS POTENTIAL; MOUSE; NONHUMAN; OVARY CANCER; POINT MUTATION; PRIORITY JOURNAL; THORACOTOMY; TUMOR SUPPRESSOR GENE; ADENOCARCINOMA; CANCER STAGING; GENETIC PREDISPOSITION; GENETICS; LUNG NEOPLASMS; MALE; PATHOLOGY; PROGNOSIS; SECONDARY;

ADENOCARCINOMA; ADULT; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GERM-LINE MUTATION; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; PROGNOSIS; PROTEIN KINASE INHIBITORS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84920621759     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000052     Document Type: Article

References (15)

1. Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004; 350: 2129-2139.
2. Rosell R, Carcereny E, Gervais R, et al.; Spanish Lung Cancer Group in collaboration with Groupe Français de Pneumo-Cancérologie and Associazione Italiana Oncologia Toracica. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial. Lancet Oncol 2012; 13: 239-246.
3. Pao W MV, Politi KA, Riely GJ, Somwar R, Zakowski MF, Kris MG, Varmus H. Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain. PLoS Med 2005; 2: 225-35.
4. Yu HA, Arcila ME, Rekhtman N, et al. Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers. Clin Cancer Res 2013; 19: 2240-2247.
5. Riely G, Yu H, Arcila M, et al. Response to Erlotinib and Prognosis in Patients with De Novo Epidermal Growth Factor Receptor T790M Mutations. J Clin Oncol 2013: 31 (suppl; abstr 8018).
6. Bell DW, Gore I, Okimoto RA, et al. Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR. Nat Genet 2005; 37: 1315-1316.
7. Meyerson M, Gabriel S, Getz G. Advances in understanding cancer genomes through second-generation sequencing. Nat Rev Genet 2010; 11: 685-696.
8. Wagle N, Emery C, Berger MF, et al. Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling. J Clin Oncol 2011; 29: 3085-3096.
9. Gnirke A, Melnikov A, Maguire J, et al. Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat Biotechnol 2009; 27: 182-189.
10. Regales L, Balak MN, Gong Y, et al. Development of new mouse lung tumor models expressing EGFR T790M mutants associated with clinical resistance to kinase inhibitors. PLoS One 2007; 2: e810.
11. Vikis H, Sato M, James M, et al. EGFR-T790M is a rare lung cancer susceptibility allele with enhanced kinase activity. Cancer Res 2007; 67: 4665-4670.
12. Girard N, Lou E, Azzoli CG, et al. Analysis of genetic variants in never-smokers with lung cancer facilitated by an Internet-based blood collection protocol: a preliminary report. Clin Cancer Res 2010; 16: 755-763.
13. Oxnard GR, Miller VA, Robson ME, et al. Screening for germline EGFR T790M mutations through lung cancer genotyping. J Thorac Oncol 2012; 7: 1049-1052.
14. Chmielecki J, Foo J, Oxnard GR, et al. Optimization of dosing for EGFRmutant non-small cell lung cancer with evolutionary cancer modeling. Sci Transl Med 2011; 3: 90ra59.
15. Imielinski M, Berger AH, Hammerman PS, et al. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell 2012; 150: 1107-1120.